Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
Betacoronavirus
COVID-19
Chemoradiotherapy
Continuity of Patient Care
/ organization & administration
Coronavirus Infections
/ epidemiology
Deglutition Disorders
/ etiology
Dental Care
Diagnostic Imaging
Head and Neck Neoplasms
/ therapy
Humans
Infection Control
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Nutrition Assessment
Occupational Exposure
/ prevention & control
Pandemics
Patient Care Team
Patient Reported Outcome Measures
Pennsylvania
/ epidemiology
Personal Protective Equipment
Physical Examination
Physical Therapy Modalities
Pneumonia, Viral
/ epidemiology
Quality Assurance, Health Care
Quality of Life
SARS-CoV-2
Speech Therapy
Surveys and Questionnaires
Survivorship
Symptom Assessment
Telemedicine
COVID-19
cancer
coronavirus
head and neck
survivorship
treatment effects
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
28
04
2020
accepted:
28
04
2020
pubmed:
19
5
2020
medline:
21
7
2020
entrez:
19
5
2020
Statut:
ppublish
Résumé
The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evidence-based approaches to the identification and management of treatment and tumor-related toxicities has embraced the use of validated patient-reported outcomes instruments, health promotion, and care coordination. In this manuscript, we describe how our multidisciplinary team of survivorship providers has accommodated to the need to provide patients with social distancing while acknowledging the importance of continued care during treatment and through the spectrum of survivorship.
Identifiants
pubmed: 32420631
doi: 10.1002/hed.26256
pmc: PMC7276867
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1668-1673Subventions
Organisme : Beckwith Institute
ID : None
Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Head Neck. 2020 Jun;42(6):1310-1316
pubmed: 32329958
J Oncol Pharm Pract. 2019 Mar;25(2):333-338
pubmed: 29050538
J Telemed Telecare. 2017 Dec;23(10):866-872
pubmed: 29081270
Head Neck. 2015 Dec;37(12):1750-5
pubmed: 24986324
CA Cancer J Clin. 2016 May;66(3):203-39
pubmed: 27002678
Laryngoscope. 2019 Dec 4;:
pubmed: 31800111
J Oncol Pract. 2015 Jan;11(1):e19-27
pubmed: 25205779
Otolaryngol Head Neck Surg. 2020 Jan;162(1):64-72
pubmed: 31613686
Otolaryngol Head Neck Surg. 2018 Nov;159(5):853-858
pubmed: 29943677
Oral Oncol. 2019 Aug;95:187-193
pubmed: 31345389
Head Neck. 2020 Jul;42(7):1668-1673
pubmed: 32420631
J Clin Oncol. 2017 Jun 20;35(18):1978-1981
pubmed: 28437163
Laryngoscope. 2019 Dec;129(12):E437-E444
pubmed: 30648277